# The Cirrhosis Outpatient Optimization, Readmission & Safety Study

> **NCT02457988** · EARLY_PHASE1 · TERMINATED · sponsor: **University of California, Los Angeles** · enrollment: 120 (estimated)

## Conditions studied

- Cirrhosis

## Interventions

- **DEVICE:** Vivify Kit

## Key facts

- **NCT ID:** NCT02457988
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 120 (ESTIMATED)
- **Why stopped:** Increased recruitment difficulties
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02457988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02457988, "The Cirrhosis Outpatient Optimization, Readmission & Safety Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02457988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*